Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Clinical trial NCT00193258 · COMPLETED

Trial details

NCT number: NCT00193258
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2004-06-01
Primary completion: 2011-01-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.